Freedom for Farmers Act of 2021 This bill abolishes the Agency for Toxic Substances and Disease Registry. This agency, which is part of the Department of Health and Human Services (HHS), investigates and responds to environmental exposures to hazardous substances in communities. HHS must transfer authority regarding certain national disease and toxic exposure registries to another appropriate HHS entity.
This bill establishes which state law governs health insurers offering coverage in multiple states. Specifically, the bill provides that the laws of a state designated by a health insurer (primary state) apply to individual health insurance coverage offered by that insurer in any other state (secondary state) if the coverage, states, and insurer comply with the conditions of this bill. Insurers are exempted from any secondary state's laws that would prohibit or regulate the operation of the insurer in that state. The primary state is given sole jurisdiction to enforce its covered laws in any secondary state. The Government Accountability Office must study the effect of this bill on specified health insurance issues.
Protection from Obamacare Mandates and Congressional Equity Act This bill alters provisions relating to the requirement to maintain minimum essential health care coverage (i.e., the individual mandate), as well as provisions relating to health care coverage for certain executive branch and congressional employees. Specifically, the bill exempts individuals from the requirement to maintain minimum essential health care coverage if they reside in a county where fewer than two health insurers offer insurance on the health insurance exchange. Under current law, there is no penalty for failing to maintain minimum essential health care coverage. The bill also requires certain executive branch and congressional employees to participate in health insurance exchanges. Under current law, Members of Congress and their designated staff are required to obtain coverage through health insurance exchanges, rather than the Federal Employee Health Benefits (FEHB) Program. Current regulations authorize government contributions toward such coverage and require Members of Congress to designate which members of their staff are required to obtain coverage through an exchange. The bill requires all congressional staff, including employees of congressional committees and leadership offices, to obtain coverage through an exchange. The bill also prohibits Members of Congress from having the discretion to determine which of their employees are eligible to enroll through an exchange. Further, the President, Vice President, and executive branch political appointees must also obtain coverage through exchanges, rather than FEHB. The government is prohibited from contributing to or subsidizing the health insurance coverage of the officials and employees subject to this requirement, including Members of Congress and their staff.
Health Coverage Choice Act This bill provides statutory authority for the Department of Treasury, the Department of Labor, and the Department of Health and Human Services rule dated August 3, 2018, regarding short-term, limited-duration health insurance plans. That rule increases the maximum authorized duration of such plans from less than 3 months (including renewals) to an initial maximum duration of less than 12 months (with a total duration of up to 36 months, including renewals).
Patient Access to Medical Foods Act This bill provides for coverage of medical foods under Medicare, Medicaid, the Children's Health Insurance Program, and TRICARE. The bill also requires private health insurance providers to cover medical foods. Generally, a medical food is a food prescribed by a physician for the dietary management of a disease or condition. The bill expands this definition to include a food prescribed as a therapeutic option when a physician determines that traditional therapies are inappropriate for the patient. This definition shall apply to the insurance programs described above and to a federal grant program to encourage the development of drugs and medical foods for rare diseases.
Protecting Constitutional Rights from Online Platform Censorship Act This bill eliminates the immunity of a provider or user of an interactive computer service (e.g., social media company) from liability for restricting certain offensive material, and it prohibits an internet platform from taking action to restrict a user's material that is protected under the Constitution or federal, state, or local law.
Byron Nash Renal Medullary Carcinoma Awareness Act of 2021 This bill allows states to receive federal payment under Medicaid for 50% of their costs for providing education on the risk of renal medullary carcinoma to individuals with sickle cell disease. (Renal medullary carcinoma is a rare kidney disease usually found in individuals with the sickle cell trait.)
Triple-Negative Breast Cancer Research and Education Act of 2021 This bill requires research and education activities related to triple-negative breast cancer. The cells of these breast cancers are negative for estrogen receptors, progesterone receptors, and excess HER2 protein, so they do not respond to hormonal therapy medicines or medicines that target the HER2 protein receptors. Specifically, the National Institutes of Health must conduct and support research into the disease. Additionally, the Centers for Disease Control and Prevention and the Health Resources and Services Administration must develop information about triple-negative breast cancer, including information regarding the elevated risk for minority women, for the public and for health care providers.
Blue Collar to Green Collar Jobs Development Act of 2021 This bill reauthorizes and modifies the Department of Energy's (DOE) Office of Minority Economic Impact. Specifically, the bill (1) renames the office as the Office of Economic Impact, Diversity, and Employment; and (2) directs the office to establish and carry out a comprehensive nationwide program to improve education and training for jobs in energy-related industries, with emphasis on increasing the number of skilled individuals from underrepresented communities trained to work in those jobs. DOE, in collaboration with the Bureau of Labor Statistics, the Department of Commerce, the Bureau of the Census, and energy-related industries, shall establish a clearinghouse to develop resources training programs for jobs in energy-related industries and act as a resource for educational institutions and covered organizations and programs that seek to develop and implement training programs for such jobs. In carrying out the program, DOE, in collaboration with the Department of Education, Commerce, the Department of Labor, and the National Science Foundation, shall develop voluntary guidelines or best practices for educational institutions to help provide students with the skills necessary for jobs in energy-related industries. The office shall establish and carry out a program to provide grants to certain businesses, labor organizations, nonprofit organizations, or qualified youth or conservation corps to pay the eligible wages or stipends for individuals receiving training to work for businesses that provide services related to renewable electric energy generation and energy efficiency.
Lung Cancer Screening Registry and Quality Improvement Act of 2021 This bill establishes several grant programs and requirements for registries that collect data from lung cancer screenings with low-dose computed tomography (LDCT) under Medicare. (Currently, for purposes of Medicare coverage, radiology imaging facilities that furnish such LDCT screenings must report certain data to approved registries.) Specifically, the bill provides funds for FY2022-FY2026 for grants to help entities establish free registries, and requires registries to be interoperable in order to receive federal funds. The bill also provides grants to support the development of related quality measures for lung cancer screenings.
Securing America's Medicine Cabinet Act of 2021 This bill encourages the development and approval of advanced pharmaceutical manufacturing technologies and designates certain university research centers to assist in developing such technologies. The Food and Drug Administration (FDA) must continue to evaluate and approve new drug manufacturing technologies included in an application for drug approval and expedite the development and implementation of such technologies. The FDA must designate such a technology as an advanced manufacturing technology if it is likely to (1) prevent or resolve a drug shortage, (2) maintain an adequate supply of critical medications for national emergencies, or (3) promote the adoption of innovative approaches to drug design and manufacturing. The sponsor of such a designated technology must provide the FDA with certain related scientific evidence. After receiving this evidence, if the FDA validates the technology for a proposed use, then the sponsor may use the validated technology across multiple manufacturing product lines within the same use context without obtaining additional FDA validation. The FDA must designate certain institutions of higher education as National Centers of Excellence in Advanced Pharmaceutical Manufacturing. Among other requirements, such centers must demonstrate the ability to provide federal agencies with technical assistance and to train a future workforce in such technologies.
Breath of Fresh Air Act This bill establishes a grant program for local educational agencies to purchase, and train school personnel to use, nebulizers.
